Integra Lifesciences Stock (NASDAQ: IART) stock price, news, charts, stock research, profile.
Open | $25.000 |
Close | $24.910 |
Volume / Avg. | 1.907M / 951.630K |
Day Range | 24.200 - 25.190 |
52 Wk Range | 22.360 - 51.115 |
Market Cap | $1.963B |
P/E Ratio | 49.176 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 3.84% |
Days to Cover | 4.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Integra Lifesciences (NASDAQ: IART) through any online brokerage.
Other companies in Integra Lifesciences’s space includes: SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Envista Holdings (NYSE:NVST), Inari Medical (NASDAQ:NARI) and Alphatec Holdings (NASDAQ:ATEC).
The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Morgan Stanley on Tuesday, May 7, 2024. The analyst firm set a price target for 24.00 expecting IART to fall to within 12 months (a possible -3.65% downside). 26 analyst firms have reported ratings in the last year.
The stock price for Integra Lifesciences (NASDAQ: IART) is $24.91 last updated May 8, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Integra Lifesciences.
Integra Lifesciences’s Q2 earnings are confirmed for Wednesday, July 24, 2024.
There is no upcoming split for Integra Lifesciences.
Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.